Brazil investigates market dumping allegations
This article was originally published in Clinica
The government in Brazil is examining allegations of market dumping by foreign companies. The investigation, involving vacuum blood sample tubes, was instigated by Brazilian company Labnew, which accuses Becton Dickinson in the UK and Terumo in the US of unfair competition.
You may also be interested in...
Azar says ACIP’s prioritization recommendations should carry weight, but states will be final arbiter of who is vaccinated.
Sanofi R&D head John Reed says the company has kept 95% of patients on its nearly 400 clinical trials, started 59 studies, and benefited from its in-house drug supply management.
The funding will be used to support clinical and preclinical development at its portfolio companies, with 8-10 programs in the clinic in 2021.